Brian Burkavage
Comptroller/Controller/Auditor bei IO BIOTECH, INC.
Vermögen: 13 570 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Brian Burkavage
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 22 | |
| Public Company | Pharmaceuticals: Major | 19 | |
| Public Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Brian Burkavage
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Treasurer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CollaGenex Pharmaceuticals, Inc. develops and markets innovative medical therapies to the dental and dermatology market. The company was founded in 1992 and is headquartered in Newtown, PA. | Pharmaceuticals: Major | General Counsel General Counsel | |
| CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member | |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder President | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| University of Notre Dame | College/University | Doctorate Degree Undergraduate Degree | |
Vicept Therapeutics, Inc.
 Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Vicept Therapeutics Inc. develops dermatologic therapeutic products. The firm develops topical agents for the treatment and prevention of a number of medical and cosmetic indications including bruising of the skin. The company was founded on July 1, 2009 by Neal Walker, Stewart D. Shanler, and Christopher V. Powala and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chairman Founder Founder | |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Aclaris Life Sciences, Inc.
 Aclaris Life Sciences, Inc. Medical/Nursing ServicesHealth Services Aclaris Life Sciences, Inc. operates as a technology-based company which focuses on rational drug design to identify novel drugs for cancer and chronic inflammatory diseases. It also engages in design and development of kinase inhibitors that target key enzymes involved in the regulation of cancer growth, survival and metastasis in modulations of chronic inflammation. The company was founded by Joseph B. Monahan, Gabriel Mbalaviele and Shaun R. Selness in 2010 and is headquartered in St. Louis, MO. | Medical/Nursing Services | Founder Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| Boston University | College/University | Doctorate Degree Masters Business Admin | |
| University of California, Los Angeles | College/University | Undergraduate Degree | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Toronto | College/University | Masters Business Admin | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
Roswell Park Comprehensive Cancer Center
 Roswell Park Comprehensive Cancer Center Hospital/Nursing ManagementHealth Services Roswell Park Comprehensive Cancer Center operates as a cancer research and treatment center. The firm?s donation services include endowment campaign, capital campaign, planned giving, honor memorial gifts, Gatwick society, and give blood. Its services include treatment services, before your first visit, the day you arrive, Roswell guide, hospital resources, drug profiles, and community resources. The company was founded in 1898 and is headquartered in Buffalo, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| The State University of New York | College/University | Undergraduate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal | |
| Icahn School of Medicine at Mount Sinai | College/University | Corporate Officer/Principal | |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Life Sciences Pennsylvania (LSPA) is a trade association that represents various entities in the life sciences industry, including biotechnology, medical device, diagnostic, pharmaceutical, research, and investment companies, as well as service providers. The non-profit company is based in Wayne, PA and has subsidiaries in the United States. The organization unifies innovators in the state to make Pennsylvania a leader in the life sciences industry. Founded in 1989, LSPA aims to create a business and public policy environment that encourages and incentivizes the diverse life sciences economy in Pennsylvania. Christopher P. Molineaux has been the CEO of the company since 2009. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin Graduate Degree | |
| ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Chairman | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MERUS N.V. | Biotechnology | Director/Board Member Director/Board Member | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| Albany Medical College | College/University | Doctorate Degree | |
NFlection Therapeutics, Inc.
 NFlection Therapeutics, Inc. BiotechnologyHealth Technology NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member | |
Galderma Canada, Inc.
 Galderma Canada, Inc. Medical/Nursing ServicesHealth Services Galderma Canada, Inc. manufactures skincare products. It manufactures therapies, such as Benzac and DIFFERIN for acne; Metrogel and Metrocream for the treatment of rosacea; CAPEX, a shampoo, which is used to treat seborrheic dermatitis of the scalp; and Apprilon, an anti-inflammatory rosacea treatment product. The company was founded in 1989 and is headquartered in Thornhill, Canada. | Medical/Nursing Services | Corporate Officer/Principal | |
| ADVERUM BIOTECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Tufts University School of Medicine | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 41 |
| Dänemark | 6 |
| Kanada | 3 |
| Vereinigtes Königreich | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 14 |
| Health Services | 4 |
| Commercial Services | 3 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 195 |
| Corporate Officer/Principal | 93 |
| Independent Dir/Board Member | 55 |
| Chief Executive Officer | 35 |
| Chairman | 30 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Claus Asbjørn Andersson | 41 |
| Jack Nielsen | 38 |
| Andrew Schiff | 35 |
| Maxine Gowen | 23 |
| Emmanuelle Coutanceau | 21 |
| Stephen Tullman | 18 |
| K. Hirth | 18 |
| David Smith | 17 |
| Athena Countouriotis | 17 |
| Bryan Reasons | 16 |
| Ben Bronstein | 16 |
| Andrew Powell | 16 |
| Mai-Britt Zocca | 13 |
| Kathleen Glaub | 13 |
| Christian Ellebæk Elling | 13 |
- Börse
- Insiders
- Brian Burkavage
- Unternehmensverbindungen